Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
· Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026
· Cash on hand..
· Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026
· Cash on hand..
· Placental Mucosal Associated Invariant T (MAIT) cells are unique unconventional immune T cells which are particularly suitable..
Italy: the largest European representation at FHA-F&B 2024 with 58 Italian exhibitors
SINGAPORE - Media OutReach..